CRL Insider Buying & Government Contracts (2026)

CRL insider buying and selling over the past year

Over the past year CHARLES RIVER LABORATORIES INTERNATIONAL, INC. insiders filed 2 open-market Form 4 trades — 1 purchases worth $4.4K and 1 sales worth $302.6K — which makes them net sellers by $298.2K.

None of the 1 sales were flagged as Rule 10b5-1 plan trades, meaning each one was a discretionary decision at the time of filing. Activity clustered in 2026-03 (1 trades) and 2026-10 (1 trades); the latest filing in this window is dated 2026-10-05. The average open-market sale price was $308.44; the last close of $300.15 is 2.7% below that level, so sellers exited above the current price. The single largest trade was a sale of 981 shares worth $302.6K on 2026-10-05. Since the most recent filing the stock has moved -3.4%, from $310.77. Insiders paid an average of $174.54 per share for their open-market purchases; against the last close of $300.15 that cost basis is sitting on a gain at +72.0%.

Where CRL trades relative to its one-year range

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. closed at $300.15 on 2026-10-16, inside a one-year range of $149.93 to $310.77. That puts the stock near the top of its range, at 93.4% of the distance from low to high. Over one year the share price moved +71.6%, and over roughly three months +33.8%. Average daily volume over the last month was about 1,008,877 shares.

Across 17 companies in the same SEC industry group (SIC 87) with a full year of prices in Gemral Edge, the median one-year return was +3.3%. CRL is ahead of that median and beat 94% of that peer group on this measure.

Members of Congress who traded CRL

STOCK Act disclosures show 7 trades in CRL by 5 members of Congress over five years (3 purchases, 4 sales), most recently on 2025-05-15. The most active traders were Jefferson Shreve (R-IN), 2 trades; Robert P. Bresnahan, Jr. (R-PA), 2 trades; Julie Johnson (D-TX), 1 trade; Lois Frankel (D-FL), 1 trade; Zoe Lofgren (D-CA), 1 trade.

By party the trades split 4 by Republicans, 3 by Democrats; by chamber, 7 from the House.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. federal contract exposure

Federal procurement records resolve 3 prime award actions to CHARLES RIVER LABORATORIES INTERNATIONAL, INC., worth $0 across 1 agencies.

Compare CRL with indexed peers from the same industry group

These peers have full Gemral Edge dossiers and the closest one-year price move to CRL:

• IQV one-year return +29.7%
• TTEK one-year return +5.9%
• ICFI one-year return +3.3%
• PAYX one-year return -11.7%
• IT one-year return -13.1%

Sources and method

Every figure above is computed from public filings stored in Gemral Edge, not estimated. Insider figures count only open-market purchases and sales reported on SEC Form 4; option exercises, grants and gifts are excluded because they do not reflect a decision to buy or sell at market prices.

• SEC EDGAR Form 4 (edge_insider_trades, codes P/S open-market only) — as of 2026-10-05
• edge_prices_eod (end-of-day close) — as of 2026-10-16
• House PTR / Senate eFD disclosures (edge_congress_trades) — as of 2025-05-15
• FPDS / USAspending (edge_contracts, tier-1 resolved) — as of 2026-09-18

CRL data questions

Are CRL insiders buying or selling stock?

Over the past year CHARLES RIVER LABORATORIES INTERNATIONAL, INC. insiders filed 2 open-market Form 4 trades — 1 purchases worth $4.4K and 1 sales worth $302.6K — which makes them net sellers by $298.2K.

What is the one-year price range for CRL?

Based on end-of-day closes through 2026-10-16, CRL traded between $149.93 and $310.77, last closing at $300.15.

Has any member of Congress traded CRL stock?

Yes. 5 members disclosed 7 trades in CRL over five years; the most recent disclosed trade date is 2025-05-15.